Elbasvir/Grazoprevir Treatment in a Hemodialysis Patient with Hepatitis C Virus Genotype 2a Infection, not Responded to Sofosbuvir/Daclatasvir Combination Therapy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Libyan Journal of Medical Sciences 2021-07, Vol.5 (3), p.132-134
Hauptverfasser: Elmelodi, Marwa, Shaibani, Badreddin, Ayad, Khairi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 134
container_issue 3
container_start_page 132
container_title Libyan Journal of Medical Sciences
container_volume 5
creator Elmelodi, Marwa
Shaibani, Badreddin
Ayad, Khairi
description
doi_str_mv 10.4103/ljms.ljms_41_21
format Article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A679538659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A679538659</galeid><sourcerecordid>A679538659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1079-458205685f618f1acf5daebf0d33a2fd6340e971374f5d78811b2b99d2db38d13</originalsourceid><addsrcrecordid>eNptUVtL7DAQLnIERX32NXBe3d1cekkfZfWsgqDo6muZNhONtElJorL-HH-pqQpHQQYyk-8yCXxZdsjoPGdULPrHIcyno8lZw9lWtssLKWc1zfM_3-ad7CCER0opr8uccbqbvZ32LYRn4xcrD69u9JhmsvYIcUAbibEEyBkOThnoN8EEcgXRTMyLiQ-JGdM1JnhJ7ox_CmSF1sXNiIQDObcau2icPSIJJNcYRmcVKhIduXHahfZpevkEuh7ixy_I0g2tsTCZyPoBPYyb_WxbQx_w4KvvZbf_TtfLs9nF5ep8eXwx6xit6lleSE6LUha6ZFIz6HShAFtNlRDAtSpFTrGumKjyxFRSMtbytq4VV62Qiom97O_n3nvosTFWu-ihG0zomuOyqgshy6JOqvkvqlQKB9M5i9ok_Idh8WnovAvBo25Gbwbwm4bRZgqv-cjtf3jiHYZQkeY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Elbasvir/Grazoprevir Treatment in a Hemodialysis Patient with Hepatitis C Virus Genotype 2a Infection, not Responded to Sofosbuvir/Daclatasvir Combination Therapy</title><source>Medknow Open Access Medical Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Elmelodi, Marwa ; Shaibani, Badreddin ; Ayad, Khairi</creator><creatorcontrib>Elmelodi, Marwa ; Shaibani, Badreddin ; Ayad, Khairi</creatorcontrib><identifier>ISSN: 2588-9044</identifier><identifier>EISSN: 2588-9044</identifier><identifier>DOI: 10.4103/ljms.ljms_41_21</identifier><language>eng</language><publisher>Medknow Publications and Media Pvt. Ltd</publisher><subject>Antiviral agents ; Care and treatment ; Genetic aspects ; Health aspects ; Hemodialysis ; Hepatitis C virus ; Infection</subject><ispartof>Libyan Journal of Medical Sciences, 2021-07, Vol.5 (3), p.132-134</ispartof><rights>COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1079-458205685f618f1acf5daebf0d33a2fd6340e971374f5d78811b2b99d2db38d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Elmelodi, Marwa</creatorcontrib><creatorcontrib>Shaibani, Badreddin</creatorcontrib><creatorcontrib>Ayad, Khairi</creatorcontrib><title>Elbasvir/Grazoprevir Treatment in a Hemodialysis Patient with Hepatitis C Virus Genotype 2a Infection, not Responded to Sofosbuvir/Daclatasvir Combination Therapy</title><title>Libyan Journal of Medical Sciences</title><subject>Antiviral agents</subject><subject>Care and treatment</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Hemodialysis</subject><subject>Hepatitis C virus</subject><subject>Infection</subject><issn>2588-9044</issn><issn>2588-9044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNptUVtL7DAQLnIERX32NXBe3d1cekkfZfWsgqDo6muZNhONtElJorL-HH-pqQpHQQYyk-8yCXxZdsjoPGdULPrHIcyno8lZw9lWtssLKWc1zfM_3-ad7CCER0opr8uccbqbvZ32LYRn4xcrD69u9JhmsvYIcUAbibEEyBkOThnoN8EEcgXRTMyLiQ-JGdM1JnhJ7ox_CmSF1sXNiIQDObcau2icPSIJJNcYRmcVKhIduXHahfZpevkEuh7ixy_I0g2tsTCZyPoBPYyb_WxbQx_w4KvvZbf_TtfLs9nF5ep8eXwx6xit6lleSE6LUha6ZFIz6HShAFtNlRDAtSpFTrGumKjyxFRSMtbytq4VV62Qiom97O_n3nvosTFWu-ihG0zomuOyqgshy6JOqvkvqlQKB9M5i9ok_Idh8WnovAvBo25Gbwbwm4bRZgqv-cjtf3jiHYZQkeY</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Elmelodi, Marwa</creator><creator>Shaibani, Badreddin</creator><creator>Ayad, Khairi</creator><general>Medknow Publications and Media Pvt. Ltd</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210701</creationdate><title>Elbasvir/Grazoprevir Treatment in a Hemodialysis Patient with Hepatitis C Virus Genotype 2a Infection, not Responded to Sofosbuvir/Daclatasvir Combination Therapy</title><author>Elmelodi, Marwa ; Shaibani, Badreddin ; Ayad, Khairi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1079-458205685f618f1acf5daebf0d33a2fd6340e971374f5d78811b2b99d2db38d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antiviral agents</topic><topic>Care and treatment</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Hemodialysis</topic><topic>Hepatitis C virus</topic><topic>Infection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elmelodi, Marwa</creatorcontrib><creatorcontrib>Shaibani, Badreddin</creatorcontrib><creatorcontrib>Ayad, Khairi</creatorcontrib><collection>CrossRef</collection><jtitle>Libyan Journal of Medical Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elmelodi, Marwa</au><au>Shaibani, Badreddin</au><au>Ayad, Khairi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elbasvir/Grazoprevir Treatment in a Hemodialysis Patient with Hepatitis C Virus Genotype 2a Infection, not Responded to Sofosbuvir/Daclatasvir Combination Therapy</atitle><jtitle>Libyan Journal of Medical Sciences</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>5</volume><issue>3</issue><spage>132</spage><epage>134</epage><pages>132-134</pages><issn>2588-9044</issn><eissn>2588-9044</eissn><pub>Medknow Publications and Media Pvt. Ltd</pub><doi>10.4103/ljms.ljms_41_21</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2588-9044
ispartof Libyan Journal of Medical Sciences, 2021-07, Vol.5 (3), p.132-134
issn 2588-9044
2588-9044
language eng
recordid cdi_gale_infotracmisc_A679538659
source Medknow Open Access Medical Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Antiviral agents
Care and treatment
Genetic aspects
Health aspects
Hemodialysis
Hepatitis C virus
Infection
title Elbasvir/Grazoprevir Treatment in a Hemodialysis Patient with Hepatitis C Virus Genotype 2a Infection, not Responded to Sofosbuvir/Daclatasvir Combination Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T07%3A45%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elbasvir/Grazoprevir%20Treatment%20in%20a%20Hemodialysis%20Patient%20with%20Hepatitis%20C%20Virus%20Genotype%202a%20Infection,%20not%20Responded%20to%20Sofosbuvir/Daclatasvir%20Combination%20Therapy&rft.jtitle=Libyan%20Journal%20of%20Medical%20Sciences&rft.au=Elmelodi,%20Marwa&rft.date=2021-07-01&rft.volume=5&rft.issue=3&rft.spage=132&rft.epage=134&rft.pages=132-134&rft.issn=2588-9044&rft.eissn=2588-9044&rft_id=info:doi/10.4103/ljms.ljms_41_21&rft_dat=%3Cgale_cross%3EA679538659%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A679538659&rfr_iscdi=true